GSDMB and neoplasm: As shown in Figure 1, GSDMB over-expression in these tumours was significantly associated with poor outcome: shorter disease free survival (DSF) and distant metastasis-free survival (DMFS) in the Ur-Rehman dataset (p < 0.001, Figure 1A–1B); as well as overall survival (OS) in the TCGA dataset (p < 0.01, Figure 1C).